3 hours Canaccord Genuity Group Lowers Edwards Lifesciences (NYSE:EW) Price Target to $66.00 MarketBeat
Canaccord Genuity Group decreased their target price on Edwards Lifesciences from $77.00 to $66.00 and set a “hold” rating for the company in a report on Monday.
Edwards Lifesciences (EW) · NYSE